Mendel.ai logo

Mendel.ai

Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.

7

Funding Rounds

$65.4m

Money raised

Overview

Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.

Funding

Funding series

Funding Series Analysis

The company Mendel.ai has raised a total of $58m in funding over 7 rounds.

Key Insights:

  • Mendel Series B round, April 2022: $40m
  • Mendel Series A round, June 2021: $18m
  • Mendel.ai Seed round, June 2018: $2.4m
  • Mendel.ai Seed round, November 2019: $3m
  • Mendel.ai funding round, July 2017: $2m
Mendel.ai logo
Mendel Series B round, April 2022 $40m
Mendel.ai logo
Mendel Series A round, June 2021 $18m
Mendel.ai logo
Mendel.ai Seed round, June 2018 $2.4m
Mendel.ai logo
Mendel.ai Seed round, November 2019 $3m
Mendel.ai logo
Mendel.ai funding round, July 2017 $2m

Industries

Mendel.ai is active in the following industries:
  • Educational Technology
  • Healthcare
  • Clinical trial
  • Genomics
  • Artificial Intelligence (AI)
  • Publishing
  • Open access
  • Cancer
  • Drug discovery
  • Drug development
  • Analytics
  • Technology
  • Oncology
  • Biology
  • Biotechnology
  • Internal medicine
  • Medicine
  • Natural language processing (NLP)